Primary mismatch repair–deficient prostate cancer can be identified prospectively in prostate biopsies and radical prostatectomies

Abida W, Cheng ML, Armenia J et al (2019) Analysis of the prevalence of microsatellite instability in prostate cancer and response to immune checkpoint blockade. JAMA Oncol 5:471–478. https://doi.org/10.1001/jamaoncol.2018.5801

Article  PubMed  Google Scholar 

Wyvekens N, Tsai HK, Sholl LM et al (2022) Histopathological and genetic features of mismatch repair-deficient high-grade prostate cancer. Histopathology 80:1050–1060. https://doi.org/10.1111/his.14645

Article  PubMed  Google Scholar 

van Dessel LF, van Riet J, Smits M et al (2019) The genomic landscape of metastatic castration-resistant prostate cancers reveals multiple distinct genotypes with potential clinical impact. Nat Commun 10:5251. https://doi.org/10.1038/s41467-019-13084-7

Article  CAS  PubMed  PubMed Central  Google Scholar 

Erson-Omay EZ, Henegariu O, Omay SB et al (2017) Longitudinal analysis of treatment-induced genomic alterations in gliomas. Genome Med 9:12. https://doi.org/10.1186/s13073-017-0401-9

Article  PubMed  PubMed Central  Google Scholar 

Graham LS, Montgomery B, Cheng HH et al (2020) Mismatch repair deficiency in metastatic prostate cancer: response to PD-1 blockade and standard therapies. PLoS ONE 15:e0233260. https://doi.org/10.1371/journal.pone.0233260

Article  CAS  PubMed  PubMed Central  Google Scholar 

留言 (0)

沒有登入
gif